8:40 a.m.Workshop Objective: What parameters should be considered when developing a high-impact biomarker?

Dennis Choi, Workshop Chair
Professor of Pharmacology and Experimental Therapeutics
Boston University
8:50 a.m.Introduction to the fNIH Biomarkers Consortium

Tom Insel
Director
National Institute of Mental Health
9:10 a.m.Lessons Learned from Alzheimer’s Disease and the NIA Alzheimer’s Disease Neuroimaging Initiative

William Potter
Vice President
Merck Research Laboratories
Clinical Neuroscience

From: B, Public Workshop on Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships

Cover of Neuroscience Biomarkers and Biosignatures
Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships, Workshop Summary.
Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders.
Washington (DC): National Academies Press (US); 2008.
Copyright © 2008, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.